Geron | GERN - Current Liabilities


Geron reported $113.82M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Amgen USD 25.49B 3.7B Dec/2025
Bio Techne USD 140.43M 4.12M Dec/2025
Cassava Sciences USD 43.83M 4.21M Dec/2025
Cytokinetics USD 202.45M 60.31M Dec/2025
Esperion Therapeutics USD 300.81M 58.22M Dec/2025
Exelixis USD 405.64M 31.86M Dec/2025
Genmab DKK 1.43B 686M Dec/2025
Geron USD 113.82M 26.11M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
Incyte USD 1.52B 176.44M Dec/2025
MacroGenics USD 43.11M 1.36M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Novavax USD 459.95M 30.08M Dec/2025